Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C21H24FN5O6.ClH |
| Molecular Weight | 497.905 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.CC(=O)NC[C@H]1CN(C(=O)O1)C2=CC(F)=C(C=C2)N3CCN(CC4=CC=C(O4)[N+]([O-])=O)CC3
InChI
InChIKey=XYGNKPXLGBABKJ-LMOVPXPDSA-N
InChI=1S/C21H24FN5O6.ClH/c1-14(28)23-11-17-13-26(21(29)33-17)15-2-4-19(18(22)10-15)25-8-6-24(7-9-25)12-16-3-5-20(32-16)27(30)31;/h2-5,10,17H,6-9,11-13H2,1H3,(H,23,28);1H/t17-;/m0./s1
| Molecular Formula | C21H24FN5O6 |
| Molecular Weight | 461.4436 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
| Molecular Formula | ClH |
| Molecular Weight | 36.461 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 23:36:17 GMT 2025
by
admin
on
Mon Mar 31 23:36:17 GMT 2025
|
| Record UNII |
X26J4H4W8H
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
392659-39-1
Created by
admin on Mon Mar 31 23:36:17 GMT 2025 , Edited by admin on Mon Mar 31 23:36:17 GMT 2025
|
PRIMARY | |||
|
6918631
Created by
admin on Mon Mar 31 23:36:17 GMT 2025 , Edited by admin on Mon Mar 31 23:36:17 GMT 2025
|
PRIMARY | |||
|
X26J4H4W8H
Created by
admin on Mon Mar 31 23:36:17 GMT 2025 , Edited by admin on Mon Mar 31 23:36:17 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
ACTIVE MOIETY |
The chemical synthesis of Ranbezolid hydrochloride. The antibacterial activity of RBx-7644 is due to the 5(S)-acetamidomethyl configuration at the oxazolidinone ring, and thus, asymmetric synthesis of only the 5(S)-enantiomer was desirable.
|